🔎 Trials Near Me

Beranda › Leukemia Mieloid Akut › Distrik Columbia › Washington

Uji klinis Leukemia Mieloid Akut di Washington, DC

24 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Menerima pesertaFase 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05564390

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06904066

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Menerima pesertaFase 3
  • Center for Cancer and Blood Disorders, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06852222

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Menerima pesertaFase 2
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Menerima pesertaFase 3
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi jauhnya
6 Months – 21 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04293562

Longitudinal Studies of Patient With FPDMM

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
1 Day – 100 Years · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT03854318

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05436418

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Menerima pesertaStudi observasional
  • The Center for Cancer and Blood Disorders, Bethesda · 7 mi jauhnya
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07154823

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Menerima pesertaFase 3
  • Children's National - Main Hospital, Washington D.C.
29 Days – 21 Years · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05183035

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 3 hingga 35 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT02390752

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Menerima pesertaFase 1
  • Childrens National Medical Center, Washington D.C.
6 Months – 80 Years · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT02203903

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
1 Day – 120 Years · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05350748

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT05588154

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Children's National Medical Center, Washington D.C.
  • Nih/Niaid, Bethesda · 7 mi jauhnya
  • Nih/Nhlbi, Bethesda · 7 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

Menerima pesertaStudi observasional
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
1 Month – 120 Years · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07019155

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Menerima pesertaFase 1/2
  • The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT04068597

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Cancer Support Community Research & Training Institute, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT02333604

Massage Impact on Sleep in Pediatric Oncology

Menerima peserta
  • Children's National Hospital, Washington D.C.
Usia 12 hingga 21 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06892158

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Menerima pesertaFase 1/2
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

Menerima pesertaFase 1/2
  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT04990102

Uji klinis Leukemia Mieloid Akut di kota lain

Studi lain di Washington

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.